2 Biotechs on Track for Profits
A number of our portfolio positions are reporting progress toward big clinical and regulatory milestones. Today we take a look at two biotechs that our on their way to hitting their goals before the end of the year. Here’s what to do…
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.